Circulating cell-free nucleic acids in cancer liquid biopsy and its clinical application / 肿瘤
Tumor
;
(12): 1260-1265, 2016.
Article
Dans Chinois
| WPRIM
| ID: wpr-848645
ABSTRACT
As the development of current advanced biotechnologies, the detection of circulating cell-free nucleic acid (cfNA) as a noninvasive liquid biopsy biomarker has emerged recently. Compared with the traditional tissue biopsy for pathological diagnostics, cfNA as a noninvasive liquid biopsy biomarker has shown many advantages, such as overcoming the heterogenicity of cancer cells and noninvasive sampling procedure. Recently, the detection of cfNA has emerged as a promising noninvasive biomarker in cancer diagnosis, prognosis prediction, and treatment response evaluation. This review article is to summarize the application of cfNA, including circulating cell-free DNA (cfDNA) and circulating cell-free RNA (cfRNA) in cancer liquid biopsy field.
Texte intégral:
Disponible
Indice:
WPRIM (Pacifique occidental)
langue:
Chinois
Texte intégral:
Tumor
Année:
2016
Type:
Article
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS